Cat. #157974
BR45 cell line
Cat. #: 157974
Unit size: 1x10^6 cells / vial
Availability: 10-12 weeks
Organism: Human
Tissue: Skin
Disease: Cancer
Model: Tumour line
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Tamar Peretz
Institute: Hadassah Medical Center; Hadasit Medical Research Services and Development Ltd.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: BR45 cell line
- Cancer: Breast cancer
- Cancers detailed: Breast cancer
- Research fields: Cancer;Drug development
- Organism: Human
- Tissue: Skin
- Disease: Cancer
- Model: Tumour line
- Description: This is a triple negative breast cancer patient's derived cell line. Histology of invasive lobular carcinoma. The line is derived from skin metastasis. When implanted to NSG mice it forms tumors. This line can serve as a platform for drug screening for cancer cells in vitro and in vivo.
- Production details: The cells were derived from metastasis (skin) in a patient with invasive duct carcinoma.
Target Details
- Target: Breast Cancer
Handling
- Format: Frozen
- Growth medium: The base medium for this cell line is DMEM with 10% bovine serum.
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
Related Tools
- Related tools: BR58 cell line ; BR98 cell line
